about
2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis: A Randomized, Noninferiority, Multi-center TrialEfficacy of granulocyte and monocyte apheresis for antibiotic-refractory pouchitis after proctocolectomy for ulcerative colitis: an open-label, prospective, multicentre study.Predicting ulcerative colitis-associated colorectal cancer using reverse-transcription polymerase chain reaction analysis.RUNX3 copy number predicts the development of UC-associated colorectal cancer.Peroral sustained-release indomethacin treatment for rectal adenomas in familial adenomatous polyposis: a pilot studyCytomegalovirus infection in ulcerative colitisComparison of QD and TID oral mesalazine for maintenance of remission in quiescent ulcerative colitis: a double-blind, double-dummy, randomized multicenter study
P50
Q33601419-6122B6AE-FA0D-4442-94AD-CC50BDD8843AQ37632264-5B89A296-728E-443C-96C9-F9C7F7EE7B81Q39715268-EDDCF351-48BD-4334-8F8A-27F7CFB9AAE3Q44891422-1350D499-3A34-4B35-B6E8-61F3BB7789DCQ74807517-78DB6882-B5C0-434D-A056-1CC31550A382Q83825410-2C53A9C0-751D-4E36-B8D4-D247A61FAC2DQ86677855-7C9C56DC-7B9D-41E4-851C-21135DB50D24
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Tadashi Yokoyama
@ast
Tadashi Yokoyama
@en
Tadashi Yokoyama
@es
Tadashi Yokoyama
@nl
type
label
Tadashi Yokoyama
@ast
Tadashi Yokoyama
@en
Tadashi Yokoyama
@es
Tadashi Yokoyama
@nl
prefLabel
Tadashi Yokoyama
@ast
Tadashi Yokoyama
@en
Tadashi Yokoyama
@es
Tadashi Yokoyama
@nl
P31
P496
0000-0003-3689-1995